BioCrossroads has added Adrienne Brown and Alan Palkowitz to its board of directors. Brown serves as vice president of US Diabetes at Eli Lilly and Co. and oversees commercial efforts for Lilly USA’s largest business unit and previously served as business unit director of Lilly Japan. Palkowitz serves as president and chief executive officer of the Indiana Biosciences Research Institute and previously served as vice president of discovery chemistry research and technologies at Eli Lilly and Co. 

“We are delighted to welcome Adrienne and Alan to our board and look forward to benefiting from their combined knowledge, capabilities and energy,” said Patty Martin, president and CEO for BioCrossroads. “Their extensive yet complementary experiences will be invaluable to BioCrossroads as we continue to ignite growth for Indiana’s life sciences industry.”

 

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}